# Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

> **NCT00014209** · PHASE2 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 77 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** cisplatin
- **DRUG:** dexamethasone
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00014209
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12-12
- **Primary completion:** 2002-07-15
- **Final completion:** 2009-02-10
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2020-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014209, "Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00014209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*